Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


GREY:VIVXF - Post by User

Avivagen Inc
Bullboard Posts
User Avatar Image
(1)
•••
Comment by KnowledgeSeeker1on Nov 20, 2012 12:39am
213 Views
Post# 20620487

RE: What up with the sell off

RE: What up with the sell off

Take this as a buying opportunity.  There has not been significant news lately to move the sp up.  I have started seeing more advertising by the company on Stockhouse here the last week when I hadn't seen any for many months.  I'm always curious when I see that happen.

There was an interview done here on Stockhouse in 2011 with the CEO that talked about achieving break even in 2013 and profitability in 2014 and so far they appear to be hitting every milestone they set so I have no reason to believe they won't do what they are saying.

They appear to be good stewards for the company and haven't diluted the shares recklessly.  Their last PP included their first institutional investor.

The sp will move on material news. This is my favorite play on the Venture and one I feel has big potential.  We just have to show patience and let the company execute.

GLTA

KnowledgeSeeker.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities